Acute ischemic stroke; WBC; prognosis.
急性缺血性卒中；白细胞；预后。
Objective: To study the role of carotid stenosis in acute ischemic stroke.
前言：目的：分析颈动脉狭窄在缺血性卒中所起的作用。
Neuroprotection is one of main therapeutic strategies for acute ischemic stroke.
脑保护是治疗急性缺血性脑血管病的主要策略之一。
Thrombolytic therapy for acute ischemic stroke is a hotspot in current medical study.
急性缺血性卒中的溶栓治疗是目前医学研究的热点。
Methods All 82 patients received intravenous urokinase (UK) for acute ischemic stroke.
方法82例急性脑梗死患者接受尿激酶(UK)静脉溶栓治疗。
For patients with acute ischemic stroke, we recommend against streptokinase (Grade 1a).
急性缺血性卒中患者，推荐不用链激酶(1a级)。
Conclusion The reporting quality of RCTs of acupuncture for acute ischemic stroke was low.
结论目前针刺治疗急性缺血性脑卒中的研究报告质量普遍较低。
This multigene approach shows potential for a point-of-care test in acute ischemic stroke.
在急性缺血性卒中这种多基因方法显示了其现场即时检验的潜力。
Diffusion-weighted imaging is the most sensitive diagnostic method for acute ischemic stroke.
磁共振弥散加权成像是急性缺血性脑卒中最敏感的诊断方法。
Take Home Point: Magnesium does not have any clear benefit in acute ischemic stroke at this time.
要点：目前镁对于急性缺血性中风还没有发现任何明显的益处。
Conclusion: Gegen injection is an effective therapy in treating patient with acute ischemic stroke.
结论：葛根素注射液是治疗急性缺血性脑梗塞的有效药物。
Conclusion Rhadiola Extract Injection is effective in treating patients with acute ischemic stroke.
结论红景天注射液对急性缺血性脑卒中的治疗有效。
Objective: Explore the ACE gene polymorphism and acute ischemic stroke predicate syndrome relevance.
目的：探讨ace基因多态性与急性缺血性中风始发证候的相关性。
Objective: To study the curative effect and safety of urokinase (UK) therapy for acute ischemic stroke.
目的：观察国产尿激酶（天普乐欣）治疗急性缺血性脑卒中的疗效及安全性。
No evidence is available using calcium antagonists in patients with acute ischemic stroke is effective.
没有证据可以佐证钙离子拮抗剂使用于急性缺血性中风病人之疗效。
The usefulness of argatroban and other thrombin inhibitors in acute ischemic stroke is not well established.
阿加曲班及其它凝血酶抑制剂在急性缺血性脑卒中中的应用效果还没有很好建立。
To determine whether calcium antagonists reduce the risk of death or dependency after acute ischemic stroke.
这篇文献回顾的目标是探讨钙离子拮抗剂是否可以降低缺血性中风后的死亡或依赖性。
Objective: To observe the therapeutic effect and safety of Strengthening anti-platelet in Acute ischemic stroke.
目的：观察强化抗血小板治疗急性缺血性脑卒中的疗效及安全性。
Objective To determine the most optional treatment time window for intravenous thrombolysis of acute ischemic stroke.
目的旨在探讨静脉溶栓治疗急性缺血性脑卒中的最佳治疗时间窗。
AIM: To study the effect and safety of low-molecular-weight heparin (LMWH) in the treatment of acute ischemic stroke.
目的：评价低分子肝素(LMWH)治疗急性缺血性中风的疗效和安全性。
Do Pretreatment MRI Scoring Systems Affect the Safety and Efficacy of Thrombolytic Therapy for Acute Ischemic Stroke?
治疗前MRI评分系统是否影响急性缺血性卒中溶栓治疗的安全性及有效性?。
Background Acute ischemic stroke has led to significant burden of human society, with high rate of mortality and dependency.
急性缺血性脑卒中已成为人类社会的重大疾病负担，具有较高的病死率和致残率。
The thrombolytic therapy in time Windows can significantly improve the clinical outcome of patients with acute ischemic stroke.
及时有效的溶栓治疗能显著改善急性缺血性脑卒中患者的临床预后。
Because many of the recommendations are based on limited data, additional research on treatment of acute ischemic stroke is needed.
因为许多推荐所基于的数据是有限的，对急性缺血性脑卒中的治疗还需进行深入的研究。
Conclusions Many brain regions had abnormal function in acute ischemic stroke patients with depressive disorder during resting state.
结论急性缺血性脑卒中伴发抑郁障碍患者在静息状态下存在多个脑区功能异常。
The disability rate of acute ischemic stroke(AIS) is very high, improve and maintain neurological function is the ultimate objective.
急性缺血性卒中的致残率很高，改善或维护患者的神经功能是治疗的最终目的。
For patients with acute ischemic stroke, we recommend against full-dose anticoagulation with IV, sc, or LMWHs or heparinoids (Grade 1b).
对于急性缺血性卒中患者，推荐不用全量抗凝，静脉输注或皮下注射低分子量肝素或类肝素(1b级)。
Conclusion: Serum level of sP selectin is elevated in acute ischemic stroke and these changes are correlated with the time after stroke.
结论：缺血性脑卒中急性期s P -选择素升高，且与发病后的时间有关。
Methods 98 patients with acute ischemic stroke were randomly divided into the treatment group and the control group, (49 patients each group).
方法将98例急性缺血性脑卒中患者随机分为治疗组和对照组，各49例。
Methods 98 patients with acute ischemic stroke were randomly divided into the treatment group and the control group, (49 patients each group).
方法将98例急性缺血性脑卒中患者随机分为治疗组和对照组，各49例。
应用推荐